300529.SZ · 健帆生物
China A-shares · RS rating 35 · As of 2026-10-14
| Price | 14.95 CNY |
|---|---|
| 1-day change | -0.5% |
| RS rating (overall / 1M / 3M / 12M) | 35 / 61 / 38 / 21 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 20 / 19 / 20 |
| Industry group (rank) | Medical-Products (64) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -15.8% |
| Distance from 52-week high | +33.2% |
| Market cap (USD) | $1.8B |